Skip to main content

Fiscal Wizard · Single-issue tearsheet

SVA / Jun 22, 2026 Run #7657

SVA

Sinovac Biotech Ltd.

Composite verdict

D 32.6 / 100
Bullish setup · Mean Reversion 1 driver · gates clear
  • Bollinger Mean Reversion
Stand aside Setup or conviction grade does not support a directional trade.

Industry rank 11th of 22 in Drug Manufacturers - General

rescore-sweep
Technical synthesisRegime: range
Bull 99%Evidence: Low · 20 signals1% Bear
Momentum Neutral 50Mean-reversion Bullish 60

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

4.6 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
P/B 75
FCF Margin 0
EBITDA Margin 0
Inventory Turnover 0

Technicals Bullish

60.7 / 100

Bullish setup leads (Bollinger Mean Reversion). · 43 signals shown.

Strongest
Weakest
Bollinger Mean Reversion 79

Risk Gates

0 blocking 4 caution

No active guards. 4 caution flags (visual only).

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Quick Ratio Caution

Visual liquidity flag — does not mute signals.

Sloan Ratio Caution

Visual accruals-quality flag — does not mute signals.

Regime Filter Bullish regime gate

Blocks signals that oppose the long-term moving-average regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for SVA.